Shen Qingrui

Shen Qingrui

This data is missing

Overview chart

, add related content, make data more complete, but also quickly upgrade, come on!

Shen Qingrui, male, born in Indonesia in 1938, returned to China in 1957 and graduated from Zhongshan Medical College (now Zhongshan Medical College of Sun Yat sen University) in 1964. Since the same year, he has been working in the First Affiliated Hospital of Sun Yat sen University. He began to work in nephrology in 1975. In 1972, peritoneal dialysis was successfully performed in the treatment of acute renal failure, which was the first case in Guangdong Province. In 1978, he participated in renal transplantation and hemodialysis, and began clinical research on hemofiltration and hemoperfusion. In 1990, plasma exchange was used to treat pre transplant hyperantibody status. From 1987 to 1988, he studied blood purification and kidney transplantation in Sweden and the United States.

Historical celebrities

(about 1742-1785 A.D.) it was originally named Yuannan, with the name of the ancients and the name Zhisheng. It was born in Changzhou, Jiangsu Province, and was the younger brother of Shen Qifeng. The year of birth and death is unknown. He was alive from the seventh year of Emperor Gaozong to the fiftieth year of Emperor Qianlong. He was under 40 years old. Shaohui is known as a little Hongbo. Qianlong Jinshi. Ruigong's poems and essays in Qing Dynasty are good at Sanqu, and his works include Shen's Qunfeng collection, yingtaohua bianyinxiao spectrum, Mencius' Yiyu, supplementary notes to historical records and Han shigu, etc., which have been handed down to the world.

Hospital Professor

editor in chief and deputy editor in chief: Practical Medical Handbook, diagnosis and treatment of kidney disease, blood purification and kidney transplantation. He participated in writing 6 monographs such as "theory and practice of internal medicine" and published 27 treatises, clinical observation and retrospective analysis reports such as "amyloidosis in maintenance hemodialysis patients", "changes of immune function in maintenance hemodialysis patients" and "polycythemia in renal transplant patients".